Evidence map›Paper›PMID 35928723›Full record

Trial reportInternational journal of medical sciences2022

A proprietary blend of standardized

Sucharitha L Pandit, Dayanand Yaligar, Manjunath Halemane, Annapoorna Bhat

2 registry-linked trialsOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in International journal of medical sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07092722 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

A Randomized, Double Blind, Placebo Controlled Parallel Arm Clinical Study to Evaluate the Efficacy of LN18178 in Improving Muscle Strength, Aerobic Capacity and Body Composition in Healthy Young Males

TypeinterventionalSponsorGENCOR Lifestage SolutionsRan2025 to 2026Enrolled120ConditionsMuscle Strength Recovery, Endurance, Healthy Human VolunteersArmsLN18178, Placebo
NCT07109622 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

A Randomized, Double-blind, Placebo-controlled Pilot Study to Evaluate the Efficacy of LN18178 on Improving Sperm Virility (Sperm Motility, Sperm Concentration, and Sperm Morphology)

TypeinterventionalSponsorGENCOR Lifestage SolutionsRan2025 to 2026Enrolled40ConditionsHealthy Human VolunteersArmsLN18178, Placebo
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
  2. A Combination ofInternational journal of medical sciences · 2025
    Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Sucharitha L PanditShetty's Hospital, Kaveri Nagar, Bengaluru-560068, Karnataka, India.
Dayanand YaligarNarayana Hrudayalaya, Bommasandra Industrial Area, Bengaluru-560068, Karnataka, India.
Manjunath HalemaneD2L Clinical Solutions, Sadaramangala Industrial Area, Bengaluru-560048, Karnataka, India.
Annapoorna BhatSri Venkateshwara Hospital, Madiwala, Bengaluru-560068, Karnataka, India.
Narayana Health · INShriram Institute for Industrial Research · INSparsh Hospital · INSri Venkateshwaraa Medical College Hospital and Research Centre · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CacaoAdultAgingDouble-Blind MethodHumansMaleMiddle AgedPlant ExtractsPomegranateTestosteronePlant Extractspomegranate fruit rindTestosteroneAging males' symptomsLN18178Muscular strengthStress alleviationTesnor®Testosterone

Identifiers

PMID35928723
PMCPMC9346391
OpenAlexW4285819555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.